Case Report: 18F-FDG PET/CT in Nonfunctioning Adrenocortical Carcinoma Relapse
https://doi.org/10.37174/2587-7593-2020-3-1-79-85
Abstract
Case report of adrenocortical carcinoma recurrence after adrenalectomy and combined treatment.
We report the case of a 46 year old man with silent adrenal mass. Imaging showed a large left adrenal mass with no evidence of distant metastasis. Complete surgical excision of the tumor was performed. After 5 years after surgical treatment, a local relapse of the disease was detected according to the results of CT, followed by PET/ CT with 18F-FDG — no evidence of distant metastases were detected. After complex treatment metastases were diagnosed by follow up PET/CT.
This case report demonstrates possibilities of PET/CT with 18F-FDG in determination of adrenal mass malignancy and in cases of recurrent adrenocortical cancer, in cases of metastatic lesions.
About the Authors
A. A. Martinovich
Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» оf the Ministry of Health of the Russian Federation
Russian Federation
Moscow.
Russian Federation
Moscow.
A. I. Mikhaylov
Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» оf the Ministry of Health of the Russian Federation
Russian Federation
Moscow.
Russian Federation
Moscow.
N. A. Meshcheriakova
Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» оf the Ministry of Health of the Russian Federation
Russian Federation
Moscow.
Russian Federation
Moscow.
M. B. Dolgushin
Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» оf the Ministry of Health of the Russian Federation
Russian Federation
Moscow.
Russian Federation
Moscow.
References
1. Roman S. Adrenocortical carcinoma. Curr Opin Oncol. 2006;18:36-42.
2. Else T, Kim AC, Sabolch A, et al. Adrenocortical carcinoma. Endocr Rev. 2014;35:282-326.
3. Lafemina J, Brennan MF. Adrenocortical carcinoma: past, present, and future. J Surg Oncol. 2012;106:586-94.
4. Chagpar R, Siperstein AE, Berber E. Adrenocortical cancer update. Surg Clin North Am. 2014;94:669-87.
5. Ayala-Ramirez M, Jasim S, Feng L, et al. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. Eur J Endocrinol. 2013;169:891-9.
6. Musella M, Conzo G, Milone M, et al. Preoperative workup in the assessment of adrenal incidentalomas: outcome from 282 consecutive laparoscopic adrenalectomies. BMC Surg. 2013;13:57.
7. Kopf D, Goretzki PE, Lehnert H. Clinical management of malignant adrenal tumors. J Cancer Res Clin Oncol. 2001;127:143-55.
8. Burotto M, Tageja N, Rosenberg A, et al. Brain metastasis in patients with adrenocortical carcinoma: a clinical series. J Clin Endocrinol Metab. 2015; 100:331-6.
9. Алексеев БЯ, Бельцевич ДГ, Бохян ВЮ и др. Клинические рекомендации — Адренокортикальный рак. 2018. МЗ РФ. [Alekseev BYa, Beltsevich DG, Bohyan VYu, et al. Clinical recommendations — Adrenocortical cancer. 2018. Ministry of Health of the Russian Federation (In Russ.)]. http://www.oncology.ru/association/clinical-guidelines/2018/adenokortikalnyi_rak_pr2018.pdf
10. Shah MH, Goldner WS, Halfdanarson TR, et al. NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2. J Natl Comprehensive Cancer Network. 2018;16(6):693-702. https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf
11. Shen WT, Sturgeon C, Duh QY. From incidentaloma to adrenocortical carcinoma: the surgical
12. management of adrenal tumors. J Surg Oncol. 2005;89(3):186-92.
Review
For citations:
Martinovich A.A., Mikhaylov A.I., Meshcheriakova N.A., Dolgushin M.B. Case Report: 18F-FDG PET/CT in Nonfunctioning Adrenocortical Carcinoma Relapse. Journal of oncology: diagnostic radiology and radiotherapy. 2020;3(1):79–85. (In Russ.) https://doi.org/10.37174/2587-7593-2020-3-1-79-85
Views:
586
Email this article 